Search
Publication
Rapid Risk Assessment: Shortage of acellular pertussis-containing vaccines and impact on immunisation programmes in the EU/EEA - 1st update, 3 February 2016
This Rapid Risk Assessment focuses on acellular pertussis-containing combination vaccines used in national vaccination programmes in the EU/EEA Member States.
Publication
Rapid Risk Assessment: Shortage of acellular pertussis-containing vaccines and impact on immunisation programmes in the EU/EEA, 13 October 2015
Early in 2015, a shortage of acellular pertussis-containing vaccines was brought to the attention of ECDC. This risk assessment provides a detailed list of mitigation options available to Member States.
Publication
Expert consultation on pertussis
This report presents the outcomes of a technical workshop, organised by ECDC, to seek a consensus on a common strategy to reduce the public health burden caused by pertussis in the EU/EEA countries.
Data
ECDC Vaccine Scheduler
The Vaccine Scheduler is an interactive tool that shows vaccination schedules for individual EU/EEA countries and specific age groups. With this tool comparisons can be made for vaccination schedules between two countries or by disease for all or a selection of countries.
- Diphtheria
- Europe
- Hepatitis A
- Hepatitis B
- Human papillomavirus infection
- Immunisation
- Influenza in humans, seasonal
- Invasive Haemophilus influenzae disease
- Measles
- Meningococcal disease
- Pertussis
- Pneumococcal disease
- Poliomyelitis
- Prevention and control
- Rotavirus infection
- Rubella
- Tetanus
- Tick-borne diseases
- Tuberculosis
- Varicella
Publication
External quality assessment (EQA) scheme on PCR for Bordetella pertussis, 2012 on behalf of the EUpert-labnet network
ECDC is publishing the first external quality assurance scheme (EQA) for Bordetalla pertusis PCR, participated by 21-one laboratories from 21 European Union/European Economic Area countries.
Publication
Pertussis Surveillance Report 2010
This surveillance report was prepared by EUVAC.net, which is a European surveillance network for vaccine-preventable diseases. The network collects data on surveillance systems and selected epidemiological characteristics of vaccine preventable diseases in the EU and other participating countries. It is jointly funded by ECDC and the Statens Serum Institut (Denmark).
Publication
Pertussis Surveillance Report 2009
This surveillance report was prepared by EUVAC.net, which is a European surveillance network for vaccine-preventable diseases. The network collects data on surveillance systems and selected epidemiological characteristics of vaccine preventable diseases in the EU and other participating countries. It is jointly funded by ECDC and the Statens Serum Institut (Denmark).
Publication
Pertussis Surveillance Report 2008
This surveillance report was prepared by EUVAC.net, which is a European surveillance network for vaccine-preventable diseases. The network collects data on surveillance systems and selected epidemiological characteristics of vaccine preventable diseases in the EU and other participating countries. It is jointly funded by ECDC and the Statens Serum Institut (Denmark).
Publication
Pertussis Surveillance Report 2003 - 2007
This surveillance report was prepared by EUVAC.net, which is a European surveillance network for vaccine-preventable diseases. The network collects data on surveillance systems and selected epidemiological characteristics of vaccine preventable diseases in the EU and other participating countries. It is jointly funded by ECDC and the Statens Serum Institut (Denmark).